France Peptide Drug Conjugates Market Size & Outlook

The peptide drug conjugates market in France is expected to reach a projected revenue of US$ 150.0 million by 2030. A compound annual growth rate of 26.3% is expected of France peptide drug conjugates market from 2024 to 2030.
Revenue, 2023 (US$M)
$29.3
Forecast, 2030 (US$M)
$150.0
CAGR, 2024 - 2030
26.3%
Report Coverage
France

France peptide drug conjugates market, 2018-2030 (US$M)

France

France peptide drug conjugates market highlights

  • The France peptide drug conjugates market generated a revenue of USD 29.3 million in 2023 and is expected to reach USD 150.0 million by 2030.
  • The France market is expected to grow at a CAGR of 26.3% from 2024 to 2030.
  • In terms of segment, therapeutics was the largest revenue generating type in 2023.
  • Therapeutics is the most lucrative type segment registering the fastest growth during the forecast period.


Peptide drug conjugates market data book summary

Market revenue in 2023USD 29.3 million
Market revenue in 2030USD 150.0 million
Growth rate26.3% (CAGR from 2023 to 2030)
Largest segmentTherapeutics
Fastest growing segmentTherapeutics
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTherapeutics, Diagnostics
Key market players worldwideNovartis AG ADR, Oncopeptides AB, Bicycle Therapeutics PLC ADR, AstraZeneca PLC, Theratechnologies Inc, Cybrexa Therapeutics, AngioChem, Soricimed


Other key industry trends

  • In terms of revenue, France accounted for 4.0% of the global peptide drug conjugates market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany peptide drug conjugates market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 123.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Peptide Drug Conjugates Market Companies

Name Profile # Employees HQ Website

France peptide drug conjugates market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peptide drug conjugates market will help companies and investors design strategic landscapes.


Therapeutics was the largest segment with a revenue share of 81.57% in 2023. Horizon Databook has segmented the France peptide drug conjugates market based on therapeutics, diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.


France is expected to witness significant growth over the forecast period owing to various initiatives undertaken by public & private organizations focusing on the development and commercialization of novel therapeutics products.

Moreover, increasing investments in developing novel advanced therapy products in the country are anticipated to support market growth over the forecast period. Such proactive government initiatives increase accessibility to treatment options, such as peptide-based drugs, thereby playing a key role in reducing the national disease burden.

The rising prevalence of target diseases is further propelling the need for effective therapeutics in the market. Moreover, cardiovascular diseases are the second leading cause of death in France, affecting someone in France every 4 minutes.

Reasons to subscribe to France peptide drug conjugates market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France peptide drug conjugates market databook

  • Our clientele includes a mix of peptide drug conjugates market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France peptide drug conjugates market , including forecasts for subscribers. This country databook contains high-level insights into France peptide drug conjugates market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France peptide drug conjugates market size, by type, 2018-2030 (US$M)

France Peptide Drug Conjugates Market Outlook Share, 2023 & 2030 (US$M)

France peptide drug conjugates market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more